An inhibitor of the 3β-HSDs: 3β-HSD1 and 3β-HSD2 (Kis = 0.10 and 1.60 μM, respectively); approved for use in reducing cortisol, aldosterone, and corticosterone levels in dogs diagnosed with Cushing's syndrome; may potentially benefit the treatment of breast cancer in postmenopausal women